CAS 1360460-82-7: Anlotinib Dihydrochloride

Description: Anlotinib dihydrochloride is a small molecule tyrosine kinase inhibitor primarily used in the treatment of various cancers, including non-small cell lung cancer and soft tissue sarcoma. It functions by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and angiogenesis. The compound is characterized by its ability to interfere with signaling pathways that promote cancer cell proliferation and survival. Anlotinib dihydrochloride is typically administered orally and is known for its favorable pharmacokinetic profile, which includes good bioavailability and a manageable half-life. The dihydrochloride form enhances its solubility and stability, making it suitable for pharmaceutical formulations. Common side effects associated with its use may include hypertension, fatigue, and gastrointestinal disturbances, reflecting its mechanism of action on vascular endothelial growth factor receptors and other kinases. Overall, Anlotinib dihydrochloride represents a significant advancement in targeted cancer therapy, offering a novel approach to managing malignancies resistant to conventional treatments.

N/A

CAS: 1058156-90-3 1360460-82-7

• Formula: C₂₃H₂₂FN₃O₃HCl
• Molecular weight: 407.45 2* 36.46

Anlotinib Dihydrochloride

CAS: 1360460-82-7

Please enquire for more information about Anlotinib Dihydrochloride including the price, delivery time and more …

• Formula: C₂₃H₂₂FN₃O₃·2HCl
• Purity: Min. 95%
• Molecular weight: 407.44 g/mol

Anlotinib Dihydrochloride

CAS: 1360460-82-7

• Formula: C₂₃H₂₂FN₃O₃· 2HCl
• Color and Shape: Neat
• Molecular weight: 407.44 + 2(36.46)